Home Your basket
• Pyogenic granuloma of the...
   Price 8.50 €
• Is HIV/AIDS an independen...
   Price 10.50 €
• Perilymphatic Gusher as a...
   Price 10.50 €
• Seven cases of inverted n...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Acoustic analysis of the ...
   Price 10.50 €
• Audiological comparison b...
   Price 14.00 €
• Postural control accordin...
   Price 10.50 €
• Oculo-orbital complicatio...
   Price 14.00 €
• Laryngeal schwannomas...
   Price 5.50 €
• Type III ossiculoplasty w...
   Price 5.50 €
• Long term results of KTP ...
   Price 5.50 €
• The eye movement autophon...
   Price 14.00 €
• Anosmia following superio...
   Price 5.50 €
• Interest of MIBI scintigr...
   Price 10.50 €
• Dysphonia in children: Re...
   Price 12.50 €
• Meniere disease : news....
   Price 10.50 €
• The place of anti-viral i...
   Price 10.50 €
• ...
   Price 5.50 €
• Pulsatile tinnitus and ve...
   Price 8.50 €
• Cine-MRI contribution to ...
   Price 10.50 €
• Speech disorders, verbal ...
   Price 10.50 €
• Soft palate ventilation: ...
   Price 14.00 €
• Subcutaneous emphysema an...
   Price 5.50 €
• Electrorhinomanometric ev...
   Price 10.50 €
• Progressive cochleo-vesti...
   Price 5.50 €
• Experimental study on sim...
   Price 10.50 €
• Results of fine needle as...
   Price 10.50 €
• Tumours of the accessory ...
   Price 10.50 €
• Vertical extended hemi cr...
   Price 5.50 €
• Social consequence of a d...
   Price 10.50 €
• Evaluation and treatment ...
   Price 8.50 €
• Trigeminal neuralgia: An ...
   Price 10.50 €

Total Order 314.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

RHINOLOGY

Mucosal melanomas of the head and neck. Experience of the Salah Azaiz Institute (Tunis).


Authors : Z. Oueslati, S. Touati, S. Gritli, A. El-May, F. Benna, H. Boussen, A. El-Khedim, M. Ferjaoui, A. Ladgham (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:237-240.

Article published in french
Downloadable PDF document french



Summary : The mucosal melanoma of the head and neck is rare and of late diagnosis. This retrospective study concerns 17 cases brought together in 30 years. Sex-ratio was of 1,1, the average age of 58 years. Tumoral seats were the following ones : nasal cavity and paranasal sinus (n=10), nasopharyngeal cavity (n=2), gingival seat (n=2), palate (n=1), laryngeal seat (n=1), middle ear (n=1). Tumoral extension was classified an follows: stage I: 52,9%, stage II: 17,6%, stage III: 29,4%. Melanomas were achromic in 23,5% of cases. On the therapeutic plan, 47,1% of the patients were treated in a purpose palliative because of the importance of the tumoral extension. Seven patients (41,2%) were treated surgically ; three among them received an additional radiotherapy for an insufficient tumoral excision or adenopathy in break capsular. Two patients (11,8%) were treated by exclusive radiotherapy. The rates of survival were 17,6% in 2 years, and 5,9% in 5 years. The average duration of survival was of 18,1 months. The causes of failure were essentially local and metastatic.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE